Status:
COMPLETED
Relationship Between Hyperventilation Syndrome and SARS-CoV-2 Infection
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
COVID-19
Hyperventilation Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Following an acute COVID-19 infection, many patients suffer from long lasting physical symptoms that may greatly impair quality of life. Persisting dyspnea and other functional respiratory complaints ...
Eligibility Criteria
Inclusion
- Read and speak French
- Perform a pulmonary function test
Exclusion
- \- incomplete questionnaire or inability to obtain an interpretable lung function assessment
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
2846 Patients enrolled
Trial Details
Trial ID
NCT05224830
Start Date
January 1 2021
End Date
July 1 2022
Last Update
September 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Régional Universitaire de Nancy.
Vandœuvre-lès-Nancy, France, 54500